acridines has been researched along with Carcinoma, Lewis Lung in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Austin, CA; Baguley, BC; Finlay, GJ; Lock, RB; Meczes, EL; Perenna Rogers, M; Sullivan, DM; Turnbull, RM | 1 |
| Baguley, BC; Denny, WA; Finlay, GJ; Haldane, A; Hay, MP | 1 |
| Anisimov, VN; Bakhtin, IuB; Iuzhakov, VV; Kaminskaia, EV; Kovalenko, AL; Kvetnoi, IM; Popovich, IG; Popuchiev, VV; Proshin, SN; Zabezhinskii, MA; Zaripova, EA | 1 |
3 other study(ies) available for acridines and Carcinoma, Lewis Lung
| Article | Year |
|---|---|
Carbamate analogues of amsacrine active against non-cycling cells: relative activity against topoisomerases IIalpha and beta.
Topics: Acridines; Amsacrine; Animals; Antigens, Neoplasm; Antineoplastic Agents; Carcinoma, Lewis Lung; Cell Cycle; CHO Cells; Cricetinae; DNA Topoisomerases, Type II; DNA-Binding Proteins; Etoposide; Humans; Isoenzymes; Mice; Poly-ADP-Ribose Binding Proteins; Saccharomyces cerevisiae; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 1999 |
Cellular uptake of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide (DACA).
Topics: Acridines; Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; Drug Resistance, Multiple; Enzyme Inhibitors; Intercalating Agents; Leukemia P388; Mice; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Tritium; Tumor Cells, Cultured | 1999 |
[Effect of cycloferon on dissemination of Lewis lung carcinoma in mice and rhabdomyosarcoma ra-23 in rats].
Topics: Acridines; Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Lewis Lung; Cell Division; Cyclophosphamide; Injections; Interferon Inducers; Mice; Mice, Inbred C57BL; Rats; Rhabdomyosarcoma | 1999 |